Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1126/sciadv.abd3916

http://scihub22266oqcxt.onion/10.1126/sciadv.abd3916
suck pdf from google scholar
32948512!7556756!32948512
unlimited free pdf from europmc32948512    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32948512      Sci+Adv 2020 ; 6 (42): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Antibody-like proteins that capture and neutralize SARS-CoV-2 #MMPMID32948512
  • Kondo T; Iwatani Y; Matsuoka K; Fujino T; Umemoto S; Yokomaku Y; Ishizaki K; Kito S; Sezaki T; Hayashi G; Murakami H
  • Sci Adv 2020[Oct]; 6 (42): ä PMID32948512show ga
  • To combat severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and any unknown emerging pathogens in the future, the development of a rapid and effective method to generate high-affinity antibodies or antibody-like proteins is of critical importance. We here report high-speed in vitro selection of multiple high-affinity antibody-like proteins against various targets including the SARS-CoV-2 spike protein. The sequences of monobodies against the SARS-CoV-2 spike protein were successfully procured within only 4 days. Furthermore, the obtained monobody efficiently captured SARS-CoV-2 particles from the nasal swab samples of patients and exhibited a high neutralizing activity against SARS-CoV-2 infection (half-maximal inhibitory concentration, 0.5 nanomolar). High-speed in vitro selection of antibody-like proteins is a promising method for rapid development of a detection method for, and of a neutralizing protein against, a virus responsible for an ongoing, and possibly a future, pandemic.
  • |Amino Acid Sequence[MESH]
  • |Angiotensin-Converting Enzyme 2[MESH]
  • |Antibodies, Immobilized/chemistry/immunology[MESH]
  • |Antibodies, Neutralizing/chemistry/immunology/metabolism[MESH]
  • |Betacoronavirus/genetics/*immunology/isolation & purification[MESH]
  • |COVID-19[MESH]
  • |Cell Surface Display Techniques/methods[MESH]
  • |Coronavirus Infections/pathology/virology[MESH]
  • |Dimerization[MESH]
  • |Humans[MESH]
  • |Kinetics[MESH]
  • |Pandemics[MESH]
  • |Peptides/chemistry/immunology[MESH]
  • |Peptidyl-Dipeptidase A/chemistry/*immunology/metabolism[MESH]
  • |Pneumonia, Viral/pathology/virology[MESH]
  • |Protein Domains/immunology[MESH]
  • |Protein Subunits/chemistry/immunology/metabolism[MESH]
  • |RNA, Viral/metabolism[MESH]
  • |SARS-CoV-2[MESH]
  • |Single-Domain Antibodies/chemistry/*immunology/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box